Oral Montelukast and Cetirizine for Thyroid Eye Disease

Abstract

The response observed in this open-label trial suggests that oral montelukast and cetirizine may be an effective medical regimen for patients with thyroid eye disease who experience mild to moderate orbital congestion and inflammation.